. 2001 Jun;158(6):2057–2066. doi: 10.1016/S0002-9440(10)64677-9

Table 2.

Nitrotyrosine Immunoreactivity in Multiple Sclerosis Tissue

Case no.	Age/sex	Sections examined and diagnosis	Nitrotyrosine reactivity^*	Regional localization
1	54 /F	5, Balo’s concentric sclerosis	4+	Lesion center and perilesional white matter
		2, NAWM		None
2	31 /F	2, Acute MS	3+	Lesion center
12	34 /F	5, Acute MS	2+	Lesion center & perilesional white matter
11	33 /F	4, Chronic active MS	+	Perilesional white matter
4	55 /F	4, Chronic silent MS	±	Lesion edge
		1, NAWM		None
13	71 /F	2, Chronic silent MS		None
14	46 /M	4, Chronic silent MS	±	Perilesional white matter
		1, NAWM		None
9	41 /M	2, Normal		None
10	35 /F	2, Normal		None

*Nitrotyrosine immunoreactivity was assessed using an arbitrary scale of 0 to 4.

NAWM: normal-appearing white matter.